NewAmsterdam Pharma Company N.V. Analysis
| Analyst Ratings |
|
Average Target Price
|
21.50
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
3
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.44
|
0.00
|
0.44
|
100.00%
|
|
2022-12-31
|
-0.40
|
0.00
|
0.40
|
100.00%
|
|
2022-09-30
|
-1.14
|
-0.27
|
0.87
|
76.38%
|
|
2022-06-30
|
0.00
|
-0.07
|
0.00
|
0.00%
|
|
2022-03-31
|
0.00
|
0.08
|
0.00
|
0.00%
|
|
2021-12-31
|
0.00
|
0.05
|
0.00
|
0.00%
|
|
2021-09-30
|
0.00
|
0.10
|
0.00
|
0.00%
|
|
2021-06-30
|
0.00
|
-0.07
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.26
|
|
2021-12-31
|
0.24
|